Clincosm LogoSign in Get a demo

A Pilot Study Using Photo-plethysmographic (PPG) Camera

Sponsor
University of California, Irvine (Other)
Overall Status
Completed
CT.gov ID
NCT01166867
Collaborator
Children's Hospital of Orange County (Other)
10
Enrollment
1
Location
11
Duration (Months)
0.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The researcher want to use video signals to monitor heart rate, respiration rate and oxygen saturation using Photo-plethysmography (PPG) as the underlying mechanism for the method: periodic changes in skin reflectance, induced by the cardio-vascular wave, are measured using light.

Condition or Disease Intervention/Treatment Phase
  • Device: Photo-plethysmography monitoring

Detailed Description

The Researcher want to use ambient light to monitor heart rate, respiration rate and oxygen saturation (SpO2) in infant patients in a hospital setting. The plethysmographic signal is typically strong on children. This provides a reliable heart rate monitor. However, to measure oxygen saturation, a quantitative value of the strength at two wavelength regions (green and red) is required. It is also not known if the normal ambient light is spectrally appropriate to analyze the video signals for oxygenation. With the current prototype of our system, we can monitor heart rate reliably and estimate oxygen saturation in adults, using normal artificial light or daylight, entering through a window.

Study Design

Study Type:
Observational
Actual Enrollment :
10 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Photo-plethysmographic (PPG) Camera to Monitor Heart Rate, Respiration Rate and Oxygen Saturation in Infants.
Study Start Date :
Sep 1, 2009
Actual Primary Completion Date :
Aug 1, 2010
Actual Study Completion Date :
Aug 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Infant Development

Photo-plethysmography monitoring

Device: Photo-plethysmography monitoring
monitoring vital sign in infant

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Minute to 12 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • infant and toddler
    Exclusion Criteria:
    • non-infant

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's Hospital of Orange County Orange California United States 92868

    Sponsors and Collaborators

    • University of California, Irvine
    • Children's Hospital of Orange County

    Investigators

    • Principal Investigator: Stuart Nelson, M.D, PhD, Beckman Laser Institute University of California Irvine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Beckman Laser Institute and Medical Center, Willem Verkruysse, Ph.D., Associate Specialist, University of California, Irvine
    ClinicalTrials.gov Identifier:
    NCT01166867
    Other Study ID Numbers:
    • NIH-LAMMP-2009-7046
    First Posted:
    Jul 21, 2010
    Last Update Posted:
    Feb 10, 2017
    Last Verified:
    Feb 1, 2017
    Keywords provided by Beckman Laser Institute and Medical Center, Willem Verkruysse, Ph.D., Associate Specialist, University of California, Irvine
    assessment

    Study Results

    No Results Posted as of Feb 10, 2017